AMARIN CORP PLC\UK Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AMARIN CORP PLC\UK share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- AMARIN CORP PLC\UK share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- AMARIN CORP PLC\UK share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 0.00 shares.
- AMARIN CORP PLC\UK share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- AMARIN CORP PLC\UK share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- AMARIN CORP PLC\UK share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 9.50K shares, a 99.23% decline from fiscal 2023.
- AMARIN CORP PLC\UK share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 1.24M shares, a 3622.68% increase from fiscal 2022.
- AMARIN CORP PLC\UK share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 33.30K shares, a 97.23% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 0.00 shares 10-K · filed 2026-03-02 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 9.50K shares 10-K · filed 2026-03-02 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | 9.50K shares derived: sum of 4 quarters · filed 2025-10-29 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | 11.00K shares derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-03-31 | 9.50K shares 10-Q · filed 2025-05-07 | 17.00K shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | 1.24M shares 10-K · filed 2025-03-12 |
| 2023-09-30 | 1.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | 1.24M shares derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | 6.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | 1.25M shares derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | 1.23M shares 10-Q · filed 2024-05-01 | 1.25M shares derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 33.30K shares 10-K · filed 2024-02-29 |
| 2022-09-30 | 8.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | 242.23K shares derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | 14.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | 418.63K shares derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | 10.60K shares 10-Q · filed 2023-05-03 | 431.13K shares derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | 208.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 1.20M shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 184.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | 1.98M shares derived: sum of 4 quarters · filed 2022-10-27 |
| 2021-06-30 | 27.14K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | 1.87M shares derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | 783.32K shares 10-Q · filed 2022-05-04 | 1.99M shares derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | 980.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 1.62M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 82.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | 1.52M shares derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | 148.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 2.10M shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | 412.46K shares 10-Q · filed 2021-04-29 | 2.57M shares derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | 875.81K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 6.00M shares 10-K · filed 2020-02-25 |
| 2019-09-30 | 663.96K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 7.82M shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | 619.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 11.64M shares derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | 3.84M shares 10-Q · filed 2020-04-30 | 11.19M shares derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-12-31 | 2.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 8.14M shares 10-K · filed 2020-02-25 |
| 2018-09-30 | 4.48M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 5.54M shares derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | 173.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | 1.09M shares derived: sum of 4 quarters · filed 2019-07-31 |
| 2018-03-31 | 782.55K shares 10-Q · filed 2019-05-01 | 967.18K shares derived: sum of 4 quarters · filed 2019-05-01 |
| 2017-12-31 | 97.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | 356.66K shares 10-K · filed 2019-02-27 |
| 2017-09-30 | 37.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 342.07K shares derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | 49.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | 315.47K shares derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | 172.03K shares 10-Q · filed 2018-05-02 | 327.80K shares derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | 82.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 177.15K shares 10-K · filed 2018-02-27 |
| 2016-09-30 | 11.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | 94.27K shares derived: sum of 4 quarters · filed 2017-11-01 |
| 2016-06-30 | 61.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 83.02K shares derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-03-31 | 21.37K shares 10-Q · filed 2017-05-03 | 37.27K shares derived: sum of 4 quarters · filed 2017-05-03 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | 18.02K shares 10-K · filed 2017-03-01 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 18.02K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2015-06-30 | 15.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 37.52K shares derived: sum of 4 quarters · filed 2016-08-04 |
| 2015-03-31 | 2.11K shares 10-Q · filed 2016-05-05 | 21.61K shares derived: sum of 4 quarters · filed 2016-05-05 |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 234.50K shares 10-K · filed 2016-02-25 |
| 2014-09-30 | 19.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | 234.50K shares derived: sum of 4 quarters · filed 2015-11-04 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 281.25K shares derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | 215.00K shares 10-Q · filed 2015-05-08 | 341.00K shares derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | 386.00K shares 10-K · filed 2015-03-03 |
| 2013-09-30 | 66.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 658.50K shares derived: sum of 4 quarters · filed 2014-11-06 |
| 2013-06-30 | 59.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 1.21M shares derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | 260.00K shares 10-Q · filed 2014-05-09 | 3.09M shares derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | 272.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | 3.38M shares 10-K · filed 2014-02-27 |
| 2012-09-30 | 622.27K shares 10-Q · filed 2012-11-08 | |
| 2012-06-30 | 1.93M shares 10-Q · filed 2012-08-08 | |
| 2012-03-31 | 554.26K shares 10-Q · filed 2013-05-09 | |
| 2011-12-31 | 2.27M shares 10-K · filed 2013-02-28 | |
| 2011-06-30 | 1.17M shares 10-Q · filed 2012-08-08 | |
| 2011-03-31 | 994.75K shares 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |